Feature Interface Biologics to focus future growth in biotech with local drug delivery platform Closely-held Interface Biologics, best known for improving the safety and efficacy of medical devices through its Endexo surface modification technology, is pegging its future growth on biotech, with an initial focus on... February 5, 2019